When it comes to preventing the spread of respiratory infections in a hospital, is it better to adopt the most stringent measures possible or a more moderate approach? One might assume it's best to go with the strictest measures possible, but what if prevention comes with a hefty price tag?
Researchers in Singapore, a country hit hard by severe acute respiratory syndrome (SARS) in 2003, compared costs of preventing the diseases spread in hospitals of three major respiratory diseases: SARS, pandemic 2009 H1N1 flu, and the Spanish flu which caused the 1918 pandemic. They found that the severity of the virus and high case-fatality rates were among the things that affected cost-effectiveness the most. Researchers determined that a calibrated approach based on the severity of the virus and community risks may help guide responses to future epidemics.
The article, “Cost-Effectiveness of Hospital Infection Control Response to an Epidemic Respiratory Virus Threat” by Paul A. Tambyah, et al. will appear in the 2009 edition of Emerging Infectious Diseases, CDC's monthly peer-reviewed scientific journal.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.